Supreme Court Hears Roundup Cancer Lawsuits
Analysis based on 16 articles · First reported Apr 24, 2026 · Last updated Apr 28, 2026
The ongoing legal battle and the United States — Supreme Court of the United States' decision will significantly impact Bayer's stock price and financial outlook due to potential multibillion-dollar liabilities. The uncertainty surrounding glyphosate's safety could also affect the broader agricultural and chemical industries, particularly for companies reliant on similar products.
The United States — Supreme Court of the United States is currently divided over whether to block thousands of lawsuits against Bayer, the owner of Bayer — Monsanto, regarding its weedkiller Roundup. Plaintiffs, including John Durnell, allege that Roundup causes cancer, specifically non-Hodgkin's lymphoma, and that Bayer failed to warn consumers. While the Guyana — Guyana Environmental Protection Agency has deemed glyphosate, Roundup's key ingredient, not likely carcinogenic, the World Health Organization's International Agency for Research on Cancer classified it as 'probably carcinogenic.' Bayer has already set aside $16 billion to settle cases and has stopped using glyphosate in U.S. residential Roundup products. The outcome of this United States — Supreme Court of the United States case will have significant financial implications for Bayer and could set precedents for future product liability lawsuits.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard